ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
22.986,82
2,01%
S&P 500
5.638,94
2,13%
Dow Jones
41.488,19
1,65%
Euro vs US Dollar
1,09215
0,00%
Bitcoin
84.143,13
0,22%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. CytoSorbents Corporation (CTSO) Börsenkurse

CytoSorbents Corporation

CytoSorbents Corporation (CTSO)

NASDAQ
1,10
0,03
(2,80%)
Geschlossen 15 März 9:00PM
Verzögert um 15 Minuten
1,10
0,00
(0,00%)
Nach Börsenschluss: 12:00AM
Verzögert um 15 Minuten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
1,10
Gebot
1,04
Fragen
1,17
Volumen
66.388
1,07 Tagesbereich 1,12
0,70 52-Wochen-Bereich 1,61
Marktkapitalisierung
60,148M
Handelsende
1,07
Handelsbeginn
1,09
Letzte Trade
396
@
1.12
(formt)
Letzter Handelszeitpunkt
Finanzvolumen
US$ 72.918
VWAP
1,0984
Durchschnittliches Volumen (3 Mio.)
268.509
Ausgegebene Aktien
54.679.569
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,15
Gewinn pro Aktie (EPS)
-0,52
Erlöse
36,35M
Nettogewinn
-28,51M

Über CytoSorbents Corporation

CytoSorbents Corp is a critical care immunotherapy leader commercializing its European Union approved CytoSorb blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients in around 55 countries. The company is conducting its pivotal REFRESH 2 - AKI cardi... CytoSorbents Corp is a critical care immunotherapy leader commercializing its European Union approved CytoSorb blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients in around 55 countries. The company is conducting its pivotal REFRESH 2 - AKI cardiac surgery trial, designed to support U.S. FDA approval. The company's product portfolio consists of CytoSorb, ContrastSorb, VetResQ, HemoDefend and others. The company has around 19 issued U.S. patents, multiple patents issued internationally, and a broad patent application portfolio pending. Geographically it derives substantial revenue from product sales in Germany. Mehr anzeigen

Sektor
Surgical,med Instr,apparatus
Branche
Surgical,med Instr,apparatus
Website
www.cytosorbents.com
Hauptsitz
Dover, Delaware, USA
Gegründet
-
CytoSorbents Corporation is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker CTSO. The last closing price for CytoSorbents was US$1,07. Over the last year, CytoSorbents shares have traded in a share price range of US$ 0,70 to US$ 1,61.

CytoSorbents currently has 54.679.569 shares in issue. The market capitalisation of CytoSorbents is US$58,51 million. CytoSorbents has a price to earnings ratio (PE ratio) of -2.15.

CTSO Neueste Nachrichten

Weitere Nachrichten

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 März 2025
CTSO (2,80%)

Form 8-K - Current report
Edgar (US Regulatory)
04 März 2025
CTSO (2,80%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
27 Februar 2025
CTSO (2,80%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
27 Februar 2025
CTSO (2,80%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
27 Februar 2025
CTSO (2,80%)

Form 8-K - Current report
Edgar (US Regulatory)
25 Februar 2025
CTSO (2,80%)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
01 Februar 2025
CTSO (2,80%)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.043.773584905661.061.120.991007611.03742528CS
4-0.27-19.70802919711.371.610.991336331.15127211CS
120.203122.64466495710.89691.610.81352685091.00225561CS
260.043.773584905661.061.610.71011920171.0168367CS
520.1111.11111111110.991.610.71443040.98564484CS
156-2.14-66.0493827163.244.590.71598061.65465516CS
260-3.13-73.99527186764.2313.890.72534185.64927117CS

CTSO - Frequently Asked Questions (FAQ)

What is the current CytoSorbents share price?
The current share price of CytoSorbents is US$ 1,10
How many CytoSorbents shares are in issue?
CytoSorbents has 54.679.569 shares in issue
What is the market cap of CytoSorbents?
The market capitalisation of CytoSorbents is USD 58,51M
What is the 1 year trading range for CytoSorbents share price?
CytoSorbents has traded in the range of US$ 0,70 to US$ 1,61 during the past year
What is the PE ratio of CytoSorbents?
The price to earnings ratio of CytoSorbents is -2,15
What is the cash to sales ratio of CytoSorbents?
The cash to sales ratio of CytoSorbents is 1,68
What is the reporting currency for CytoSorbents?
CytoSorbents reports financial results in USD
What is the latest annual turnover for CytoSorbents?
The latest annual turnover of CytoSorbents is USD 36,35M
What is the latest annual profit for CytoSorbents?
The latest annual profit of CytoSorbents is USD -28,51M
What is the registered address of CytoSorbents?
The registered address for CytoSorbents is 874 WALKER RD STE C, KENT, DOVER, DELAWARE, 19904
What is the CytoSorbents website address?
The website address for CytoSorbents is www.cytosorbents.com
Which industry sector does CytoSorbents operate in?
CytoSorbents operates in the SURGICAL,MED INSTR,APPARATUS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
RDUSRadius Recycling Inc
US$ 27,902
(104,26%)
8,53M
BONBon Natural Life Ltd
US$ 1,40
(90,29%)
84M
SUNESUNation Energy Inc
US$ 0,5213
(62,96%)
513,96M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 255,00
(39,80%)
222
AAOIApplied Optoelectronics Inc
US$ 22,105
(39,29%)
17,01M
GLSTUGlobal Star Acquisition Inc
US$ 2,00
(-69,23%)
421
CURRCurrenc Group Inc
US$ 2,03
(-41,33%)
1,42M
ADTXAditxt Inc
US$ 0,0201
(-39,82%)
240,2M
HEPAHepion Pharmaceuticals Inc
US$ 0,0228
(-39,68%)
161,52M
WKSPWorksport Ltd
US$ 0,36205
(-35,45%)
4,96M
SUNESUNation Energy Inc
US$ 0,5213
(62,96%)
513,96M
NVDANVIDIA Corporation
US$ 121,67
(5,27%)
277,56M
ADTXAditxt Inc
US$ 0,0201
(-39,82%)
240,2M
HEPAHepion Pharmaceuticals Inc
US$ 0,0228
(-39,68%)
161,52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,225
(7,64%)
160,21M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
CTSO
CytoSorbents
TSXV
SNM
ShaMaran Petroleum
USOTC
TDGMW
Tidewater (QX)
DOWI
DJUSWU
DJ US Water
DOWI
DJIEZS
DJ Islamic Market Euro S...
DOWI
DWDVHC
DJ Global Developed Heal...
COIN
IGNISUSD
Ignis
NASDAQ
ANSS
ANSYS
DOWI
DJTFVS
DJ Financial Services Ti...
ASX
VAUKOA
Citigroup Global Markets...
COIN
50XUSD
50x.com
TSXV
ERE.UN
European Residetial Real...
AMEX
URG
Ur Energy
DOWI
DJUSTP
DJ US TopCap
LSE
LRS
COIN
REPEUR
Augur Reputation v2
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten